Thomas Glaab

2.9k total citations · 1 hit paper
50 papers, 2.1k citations indexed

About

Thomas Glaab is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thomas Glaab has authored 50 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 27 papers in Physiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thomas Glaab's work include Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers), Asthma and respiratory diseases (26 papers) and Respiratory Support and Mechanisms (11 papers). Thomas Glaab is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (30 papers), Asthma and respiratory diseases (26 papers) and Respiratory Support and Mechanisms (11 papers). Thomas Glaab collaborates with scholars based in Germany, United States and Italy. Thomas Glaab's co-authors include Claus Vogelmeier, Armin Braun, Leonardo M. Fabbri, Klaus F. Rabe, Hendrik Schmidt, Kai Michael Beeh, Marion Wencker, Christian Taube, Péter Kardos and Maureen Rutten‐van Mölken and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Thomas Glaab

49 papers receiving 2.0k citations

Hit Papers

Tiotropium versus Salmeterol for the Prevention of Exacer... 2011 2026 2016 2021 2011 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
    2011 484 citations Claus Vogelmeier, Bettina Hederer et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Glaab Germany 23 1.4k 1.2k 177 137 122 50 2.1k
Philip W. Ind United Kingdom 23 1.3k 0.9× 1.2k 1.0× 182 1.0× 75 0.5× 112 0.9× 66 2.1k
Masaya Takemura Japan 31 2.1k 1.5× 1.4k 1.2× 230 1.3× 89 0.6× 114 0.9× 120 3.0k
Paula Rytilä Finland 26 1.3k 0.9× 1.2k 1.0× 133 0.8× 57 0.4× 70 0.6× 52 2.0k
Krishnan Parameswaran Canada 23 1.3k 0.9× 1.6k 1.4× 286 1.6× 49 0.4× 61 0.5× 33 2.2k
Caterina Bucca Italy 31 1.7k 1.2× 1.9k 1.6× 193 1.1× 28 0.2× 144 1.2× 117 3.0k
T Kava Finland 16 2.0k 1.4× 2.5k 2.1× 192 1.1× 167 1.2× 167 1.4× 20 3.0k
Diahn‐Warng Perng Taiwan 21 805 0.6× 822 0.7× 266 1.5× 28 0.2× 118 1.0× 68 1.6k
D W Empey United Kingdom 18 1.1k 0.7× 827 0.7× 75 0.4× 56 0.4× 356 2.9× 52 1.8k
ST Holgate United Kingdom 25 1.3k 0.9× 1.9k 1.6× 377 2.1× 102 0.7× 65 0.5× 83 2.4k
Patricia McClean United Kingdom 29 1.6k 1.1× 1.2k 1.0× 60 0.3× 23 0.2× 225 1.8× 93 3.1k

Countries citing papers authored by Thomas Glaab

Since Specialization
Citations

This map shows the geographic impact of Thomas Glaab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Glaab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Glaab more than expected).

Fields of papers citing papers by Thomas Glaab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Glaab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Glaab. The network helps show where Thomas Glaab may publish in the future.

Co-authorship network of co-authors of Thomas Glaab

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Glaab. A scholar is included among the top collaborators of Thomas Glaab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Glaab. Thomas Glaab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glaab, Thomas & Armin Braun. (2021). Noninvasive Measurement of Pulmonary Function in Experimental Mouse Models of Airway Disease. Lung. 199(3). 255–261. 13 indexed citations
2.
Glaab, Thomas, et al.. (2016). Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany. Respiratory Medicine. 118. 58–64. 9 indexed citations
3.
Beeh, Kai Michael, Thomas Glaab, Susanne Stowasser, et al.. (2013). Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial. Respiratory Research. 14(1). 116–116. 63 indexed citations
4.
Müller, Matthias, Harald Kögler, Thomas Glaab, & Tobias Welte. (2012). COPD-Screening in der hausärztlichen Praxis mit einem Lungenfunktions-Schnellmessgerät. Pneumologie. 66(11). 645–649. 6 indexed citations
5.
Vogelmeier, Claus, Leonardo M. Fabbri, Klaus F. Rabe, et al.. (2012). Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients. Respiratory Medicine. 107(1). 75–83. 15 indexed citations
6.
Buhl, Roland, Tobias Welte, Claus Vogelmeier, et al.. (2012). Evidenz für eine frühzeitige Therapie der COPD mit Tiotropium. Pneumologie. 66(10). 589–595. 1 indexed citations
7.
Dellweg, Dominic, Herbert Wachtel, Michael Pieper, et al.. (2011). In Vitro Validation of a Respimat ® Adapter for Delivery of Inhaled Bronchodilators During Mechanical Ventilation. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 24(6). 285–292. 13 indexed citations
8.
Glaab, Thomas, et al.. (2011). A practical guide to bioelectrical impedance analysis using the example of chronic obstructive pulmonary disease. Nutrition Journal. 10(1). 35–35. 103 indexed citations
9.
Vogelmeier, Claus, Bettina Hederer, Thomas Glaab, et al.. (2011). Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD. New England Journal of Medicine. 364(12). 1093–1103. 484 indexed citations breakdown →
10.
Glaab, Thomas & Christian Taube. (2010). Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease. Pulmonary Pharmacology & Therapeutics. 24(1). 15–22. 12 indexed citations
11.
Kögler, Harald, Norbert Metzdorf, Thomas Glaab, & Tobias Welte. (2010). Preselection of patients at risk for COPD by two simple screening questions. Respiratory Medicine. 104(7). 1012–1019. 14 indexed citations
12.
Gillissen, A, et al.. (2009). Statistical analysis of chronic obstructive pulmonary disease exacerbations in clinical studies: expectations and limitations.. PubMed. 60 Suppl 5. 7–11. 2 indexed citations
13.
Beeh, Kai Michael & Thomas Glaab. (2009). Is There a Role for Antiinflammatory Treatment in COPD?. COPD Journal of Chronic Obstructive Pulmonary Disease. 6(5). 395–403. 3 indexed citations
14.
Kardos, Péter, Marion Wencker, Thomas Glaab, & Claus Vogelmeier. (2007). Avoiding Mistakes in Calculating the Number Needed to Treat in Severe COPD. American Journal of Respiratory and Critical Care Medicine. 175(12). 1347–1348. 1 indexed citations
15.
Skripuletz, Thomas, Andreas Schmiedl, J Schade, et al.. (2007). Dose-dependent recruitment of CD25+ and CD26+ T cells in a novel F344 rat model of asthma. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(6). L1564–L1571. 30 indexed citations
16.
Kardos, Péter, Marion Wencker, Thomas Glaab, & Claus Vogelmeier. (2006). Impact of Salmeterol/Fluticasone Propionate versus Salmeterol on Exacerbations in Severe Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 175(2). 144–149. 245 indexed citations
17.
Glaab, Thomas, Norbert Banik, Marcel Trautmann, A. Hellmann, & Marion Wencker. (2006). COPD-Management nach aktuellen Leitlinien bei niedergelassenen Pneumologen. Pneumologie. 60(7). 395–400. 6 indexed citations
18.
Glaab, Thomas, Norbert Banik, Charles R.J. Singer, & Marion Wencker. (2006). Leitlinienkonforme ambulante COPD-Behandlung in Deutschland. DMW - Deutsche Medizinische Wochenschrift. 131(21). 1203–1208. 12 indexed citations
19.
Fuchs, Barbara, Wilfried Bautsch, Jörg Köhl, et al.. (2005). Pharmacological Targeting of Anaphylatoxin Receptors during the Effector Phase of Allergic Asthma Suppresses Airway Hyperresponsiveness and Airway Inflammation. The Journal of Immunology. 174(2). 783–789. 90 indexed citations
20.
Glaab, Thomas, H. G. Hoymann, Matthias Hecht, et al.. (2003). Effect of anti‐nerve growth factor on early and late airway responses in allergic rats. Allergy. 58(9). 900–904. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip W. Ind Breakdown of academic impact, for papers by Masaya Takemura Breakdown of academic impact, for papers by Paula Rytilä Breakdown of academic impact, for papers by Krishnan Parameswaran Breakdown of academic impact, for papers by Caterina Bucca Breakdown of academic impact, for papers by T Kava Breakdown of academic impact, for papers by Diahn‐Warng Perng Breakdown of academic impact, for papers by D W Empey Breakdown of academic impact, for papers by ST Holgate Breakdown of academic impact, for papers by Patricia McClean
Rankless by CCL
2026